AR015140A1 - N-(3,4-dihidro-2h-piran-4-il)sulfonamidas, procedimiento para su preparacion, su utilizacion para la preparacion de un medicamento, un preparadofarmaceutico y medicamento - Google Patents
N-(3,4-dihidro-2h-piran-4-il)sulfonamidas, procedimiento para su preparacion, su utilizacion para la preparacion de un medicamento, un preparadofarmaceutico y medicamentoInfo
- Publication number
- AR015140A1 AR015140A1 ARP980103831A ARP980103831A AR015140A1 AR 015140 A1 AR015140 A1 AR 015140A1 AR P980103831 A ARP980103831 A AR P980103831A AR P980103831 A ARP980103831 A AR P980103831A AR 015140 A1 AR015140 A1 AR 015140A1
- Authority
- AR
- Argentina
- Prior art keywords
- group
- hydrogen
- preparation
- alkyl
- replaced
- Prior art date
Links
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940126601 medicinal product Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000825 pharmaceutical preparation Substances 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 10
- 239000001257 hydrogen Substances 0.000 abstract 10
- -1 N- (3,4-dihydro-2H-pyran-4-yl) sulfonamides Chemical class 0.000 abstract 6
- 125000002947 alkylene group Chemical group 0.000 abstract 5
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 5
- 125000006273 (C1-C3) alkyl group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- 125000005004 perfluoroethyl group Chemical group FC(F)(F)C(F)(F)* 0.000 abstract 3
- 125000005009 perfluoropropyl group Chemical group FC(C(C(F)(F)F)(F)F)(F)* 0.000 abstract 3
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 abstract 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 125000006681 (C2-C10) alkylene group Chemical group 0.000 abstract 1
- 125000004214 1-pyrrolidinyl group Chemical group [H]C1([H])N(*)C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 101150020251 NR13 gene Proteins 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000002883 imidazolyl group Chemical group 0.000 abstract 1
- 125000005936 piperidyl group Chemical group 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 125000001544 thienyl group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Abstract
N-(3,4-dihidro-2H-piran-4-il)sulfonamidas, que comprenden compuestos de la formula (I), en la que significan: R1 y R2 independientemente uno del otro,hidrogeno, CF3, C2F5, C3F7, alquilo C1-6 o fenilo, que está sin sustituir o sustituido con 1 o 2 sustituyentes seleccionados entre el grupo que consta de F,Cl, Br, I, CF3, metilo, metoxi, sulfamoílo y metilsulfonilo; o R1 y R2 en comun, una cadena de alquileno C2-10; pudiendo un grupo CH2 de la cadena de alquilenoestar reemplazado por -O-, -CO-, -S-, -SO-, -SO2- o -NR10-; R10 es hidrogeno o alquilo C1-3; R3 es R12-CaH2a[NR13]m-; donde R12 es hidrogeno o cicloalquiloC3-8, CF3, C2F5 o C3F7; a es 0, 1, 2, 3, 4, 5, 6, 7, 8, 9 o 10; m es 0 o 1; R13 es hidrogeno o alquilo C1-6; o R12 y R13 en comun,un grupo alquileno C4-8,pudiendo un grupo CH2 del grupo alquileno estar reemplazado por -O-, -[SO0, 1 o 2]-, -CO- o -NR10-; siendo R10 hidrogeno o alquilo C1-3; R4 es R14-CrH2r; r es0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19 o 20; R14 es hidrogeno, cicloalquilo C3-8, piperidilo, 1-pirrolidinilo, N-morfolino,N-metil-piperazino, CF3, C2F5, C3F7, piridilo, tienilo, imidazolilo o fenilo, que está sin sustituir o sustituido co 1 o 2 sustituyentes seleccionados entre elgrupoque consta de F, Cl, Br, I, CF3, metilo, metoxi, sulfamoílo, metilsulfonilo y metilsulfonilamino; pudiendo un grupo CH2 del grupo CrH2r estar reemplazadopor -O-, -CH=CH-, -C=C-, -CO-, -CO-O-, -CO-NR11-, -[SOo, 1 o 2]- o -NR11-; siendo R11 hidrogenoo -(CaH2a)-R10; pudiendo un grupo CH2 del grupo CaH2a estarreemplazado por -O-, -CH=CH-, -C=C-, -CO-, -CO-O-, -O-CO-, -S-, -SO-, -SO2-, -NR10- o -CONR10-; R10 es hidrogeno o alquilo C1-3; o R3 y R4 en comun, una cadenade alquileno C3-8; pudiendo un grupo CH2 de la cadena de alquileno estar reemplazado por -O-, -[SO0, 1 o 2]-, -CO- o -NR11-; R11 es hidrogeno o -CaH2a-R10,pudiendo un grupo CH2 del grupo CaH2a estar reemplazado por -O-, -CH=CH-, -C=C-, -CO-, -CO-O-, -O-CO-, -S-, -SO-, -SO2-, -NR10-o -CONR10-; siendo R10hidrogeno o alquilo C1-3; R5 y R6 son -CR15=CR16-CR17=N-, -CR15=CR16-N=CR17-, -CR15=N-CR17=N-, -CR15=N-N=CR17-, -N=CR16-CR17=N- o -S-CR15=CR16-; siendo R15,
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19733779A DE19733779A1 (de) | 1997-08-05 | 1997-08-05 | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE1997147889 DE19747889A1 (de) | 1997-10-30 | 1997-10-30 | Sulfonamid-substituierte Verbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR015140A1 true AR015140A1 (es) | 2001-04-18 |
Family
ID=26038867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980103831A AR015140A1 (es) | 1997-08-05 | 1998-08-03 | N-(3,4-dihidro-2h-piran-4-il)sulfonamidas, procedimiento para su preparacion, su utilizacion para la preparacion de un medicamento, un preparadofarmaceutico y medicamento |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US6184221B1 (es) |
| EP (1) | EP0895994A3 (es) |
| JP (1) | JPH11100382A (es) |
| KR (1) | KR19990023304A (es) |
| CN (1) | CN1207391A (es) |
| AR (1) | AR015140A1 (es) |
| AU (1) | AU742918B2 (es) |
| BR (1) | BR9803739A (es) |
| CA (1) | CA2244577A1 (es) |
| CZ (1) | CZ243598A3 (es) |
| HR (1) | HRP980426A2 (es) |
| HU (1) | HUP9801789A3 (es) |
| ID (1) | ID20718A (es) |
| IL (1) | IL125642A (es) |
| NO (1) | NO983577L (es) |
| NZ (1) | NZ331230A (es) |
| PL (1) | PL327849A1 (es) |
| SK (1) | SK104298A3 (es) |
| TR (1) | TR199801492A3 (es) |
| TW (1) | TW526200B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU754204B2 (en) * | 1998-09-01 | 2002-11-07 | Bristol-Myers Squibb Company | Potassium channel inhibitors and method |
| GB0315950D0 (en) * | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
| WO2006061642A1 (en) * | 2004-12-09 | 2006-06-15 | Xention Discovery Limited | Compounds |
| US7576212B2 (en) * | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
| GB0525164D0 (en) * | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| US7999107B2 (en) | 2007-01-31 | 2011-08-16 | Merck Sharp & Dohme Corp. | Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3008360C2 (de) | 1980-03-05 | 1982-04-22 | Chemische Werke Hüls AG, 4370 Marl | Verwendung von Copolyestern als Schmelzkleber zur Kantenverleimung |
| NZ230711A (en) * | 1988-09-23 | 1990-10-26 | Ortho Pharma Corp | Substituted thienopyrans as antihypertensive agents |
| US5428031A (en) | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| EP0807629B1 (de) * | 1996-05-15 | 2004-03-03 | Aventis Pharma Deutschland GmbH | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE19706675A1 (de) * | 1997-02-20 | 1998-08-27 | Hoechst Ag | Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1998
- 1998-07-30 EP EP98114307A patent/EP0895994A3/de not_active Withdrawn
- 1998-08-03 NZ NZ331230A patent/NZ331230A/en unknown
- 1998-08-03 IL IL12564298A patent/IL125642A/en not_active IP Right Cessation
- 1998-08-03 KR KR1019980031470A patent/KR19990023304A/ko not_active Application Discontinuation
- 1998-08-03 ID IDP981070A patent/ID20718A/id unknown
- 1998-08-03 TR TR1998/01492A patent/TR199801492A3/tr unknown
- 1998-08-03 TW TW087112714A patent/TW526200B/zh active
- 1998-08-03 AR ARP980103831A patent/AR015140A1/es unknown
- 1998-08-03 CZ CZ982435A patent/CZ243598A3/cs unknown
- 1998-08-03 HR HR19747889.1A patent/HRP980426A2/hr not_active Application Discontinuation
- 1998-08-03 SK SK1042-98A patent/SK104298A3/sk unknown
- 1998-08-04 US US09/128,664 patent/US6184221B1/en not_active Expired - Fee Related
- 1998-08-04 CN CN98116752A patent/CN1207391A/zh active Pending
- 1998-08-04 NO NO983577A patent/NO983577L/no unknown
- 1998-08-04 HU HU9801789A patent/HUP9801789A3/hu unknown
- 1998-08-04 CA CA002244577A patent/CA2244577A1/en not_active Abandoned
- 1998-08-04 AU AU78661/98A patent/AU742918B2/en not_active Ceased
- 1998-08-04 BR BR9803739A patent/BR9803739A/pt not_active IP Right Cessation
- 1998-08-04 JP JP10220387A patent/JPH11100382A/ja not_active Withdrawn
- 1998-08-05 PL PL98327849A patent/PL327849A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TR199801492A2 (xx) | 1999-02-22 |
| HUP9801789A3 (en) | 2001-02-28 |
| TR199801492A3 (tr) | 1999-02-22 |
| NZ331230A (en) | 2000-06-23 |
| CA2244577A1 (en) | 1999-02-05 |
| NO983577D0 (no) | 1998-08-04 |
| HUP9801789A2 (hu) | 1999-09-28 |
| IL125642A (en) | 2002-11-10 |
| BR9803739A (pt) | 2000-03-21 |
| HU9801789D0 (en) | 1998-09-28 |
| IL125642A0 (en) | 1999-04-11 |
| ID20718A (id) | 1999-02-18 |
| KR19990023304A (ko) | 1999-03-25 |
| EP0895994A3 (de) | 1999-12-15 |
| CN1207391A (zh) | 1999-02-10 |
| CZ243598A3 (cs) | 1999-02-17 |
| US6184221B1 (en) | 2001-02-06 |
| JPH11100382A (ja) | 1999-04-13 |
| NO983577L (no) | 1999-02-08 |
| AU7866198A (en) | 1999-02-18 |
| AU742918B2 (en) | 2002-01-17 |
| SK104298A3 (en) | 1999-02-11 |
| PL327849A1 (en) | 1999-02-15 |
| TW526200B (en) | 2003-04-01 |
| EP0895994A2 (de) | 1999-02-10 |
| HRP980426A2 (en) | 1999-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA200300792A1 (ru) | Хиназолины в качестве ингибиторов ммр-13 | |
| ES2192394T3 (es) | Profarmacos de inhibidores de la bomba de protones. | |
| DK490288A (da) | Substituerede thiazolidindionderivater | |
| AR031531A1 (es) | Derivados de las sulfonamidas que poseen actividad modulatoria e inhibitoria de las jun-quinasas (jnk), uso de dichos derivados en la preparacion de composiciones para dichos tratamientos y composiciones farmaceuticas formuladas con dichos derivados. | |
| HUP0402026A2 (hu) | 5,6-Diaril-pirazin-2-amid-származékok mint CB1 antagonisták, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények | |
| AR033408A1 (es) | Compuestos de bisarilo que contienen nitrogeno orto, orto-sustituidos, procedimientos para su preparacion, su utilizacion para la preparacion de un medicamento como tambien composiciones farmaceuticas que los contienen | |
| MX9305379A (es) | Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene. | |
| AR036107A1 (es) | Derivados de 6-fenilpirrolpirimidindiona, antagonista de los receptores a2 de la adenosina, particularmente del subtipo a2, de aplicacion en la prevencion de la degranulacion de los mastocitos; composiciones farmaceuticas formuladas con dichos compuestos y uso de los mismos en la preparacion de medi | |
| AR032453A1 (es) | Derivados alquinil fenil heteroaromaticos activadores de glucoquinasa, un proceso para su preparacion, composiciones farmaceuticas, el uso de dichos derivados para la preparacion de medicamentos | |
| DK0783490T3 (da) | 1-Acyl-4-alifatiske aminopiperidinforbindelser | |
| NO940503D0 (no) | Forbindelser med en sulfamoyl - og amidinogruppe, fremgangsmåte for fremstilling av dem og farmasöytiske blandinger som inneholder dem | |
| FI950016A0 (fi) | Heterosykliset yhdisteet lääkeaineena | |
| KR890701557A (ko) | 리폭시게나제 억제화합물을 함유하는 푸란 및 피롤 | |
| KR880009928A (ko) | N-헤테로시클릭-n(4-피페리딜) 아미드와 이러한 화합물들을 사용하는 방법 및 제약학적 조성물 | |
| ES2116555T3 (es) | Nuevos derivados naftalenicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen. | |
| TR199801210T2 (xx) | 1-(1,2-�ift ikameli piperidinil)-4-(kayna�m�� imidazol)piperidin t�revleri. | |
| KR920006322A (ko) | 벤젠, 피리딘 및 피리미딘 유도체 | |
| MA23639A1 (fr) | Derives pyrrocarbazole, leur preparation, les compositions pharmaceutiques les contenant, leur utilisation dans le traitement des tumeurs malignes. | |
| AR015140A1 (es) | N-(3,4-dihidro-2h-piran-4-il)sulfonamidas, procedimiento para su preparacion, su utilizacion para la preparacion de un medicamento, un preparadofarmaceutico y medicamento | |
| RU2003130752A (ru) | Противозудные средства | |
| DE59814334D1 (de) | 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung als Inhibitoren der Leukozytenadhäsion und sie enthaltende pharmazeutische Präparate | |
| DE60011110D1 (de) | Pharmazeutisch wirksame sulfonyl hydrazid-derivate | |
| RU2006104024A (ru) | Каппа-агонисты, в особенности для лечения и/или профилактики синдрома раздраженной толстой кишки | |
| DE69103968T2 (de) | 2-(Aminoalkyl)-5-(arylalkyl)1,3-dioxanderivate, ihre Herstellung und ihre Anwendung in der Therapeutik. | |
| AR024219A1 (es) | COMPUESTOS DE QUINOLONAS 2-(NH- U O-SUSTITUIDAS) UTILES COMO INHIBIDORES DE LA METIONIL t-RNA SINTETASA (MRS) COMPOSICIONES FARMACEUTICAS FORMULADAS CONDICHOS COMPUESTOS; PROCEDIMIENTO PARA SU PREPARACION Y USO DE DICHOS COMPUESTOS PARA PREPARAR MEDICAMENTOS PARA EL TRATAMIENTO DE INFECCIONES BACTER |